BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38331339)

  • 1. Pentoxifylline protects against cerebral ischaemia-reperfusion injury through ferroptosis regulation via the Nrf2/SLC7A11/GPX4 signalling pathway.
    Li P; Chen JM; Ge SH; Sun ML; Lu JD; Liu F; Wang LL; Zhang X; Wang XP
    Eur J Pharmacol; 2024 Mar; 967():176402. PubMed ID: 38331339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhein attenuates cerebral ischemia-reperfusion injury via inhibition of ferroptosis through NRF2/SLC7A11/GPX4 pathway.
    Liu H; Zhang TA; Zhang WY; Huang SR; Hu Y; Sun J
    Exp Neurol; 2023 Nov; 369():114541. PubMed ID: 37714424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ozone-mediated cerebral protection: Unraveling the mechanism through ferroptosis and the NRF2/SLC7A11/GPX4 signaling pathway.
    Zhu F; Ding S; Liu Y; Wang X; Wu Z
    J Chem Neuroanat; 2024 Mar; 136():102387. PubMed ID: 38182039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine exerts its protective effect on cerebral ischemia reperfusion injury in mice by inhibiting ferroptosis.
    Hu M; Men Y; Chen L; Huang J; Duan F; Zhang Y; Dong S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):600-609. PubMed ID: 35753730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats.
    Hu Q; Zuo T; Deng L; Chen S; Yu W; Liu S; Liu J; Wang X; Fan X; Dong Z
    Phytomedicine; 2022 Jul; 102():154112. PubMed ID: 35550220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia.
    Fu C; Wu Y; Liu S; Luo C; Lu Y; Liu M; Wang L; Zhang Y; Liu X
    J Ethnopharmacol; 2022 May; 289():115021. PubMed ID: 35091012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of MALT1 reduces ferroptosis in rat hearts following ischemia/reperfusion via enhancing the Nrf2/SLC7A11 pathway.
    Jiang YQ; Yang XY; Duan DQ; Zhang YY; Li NS; Tang LJ; Peng J; Luo XJ
    Eur J Pharmacol; 2023 Jul; 950():175774. PubMed ID: 37146710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 attenuates oxidative stress to mediate the protective effect of ciprofol against cerebral ischemia-reperfusion injury.
    Liu X; Ren M; Zhang A; Huang C; Wang J
    Funct Integr Genomics; 2023 Nov; 23(4):345. PubMed ID: 37996761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shenmai Injection Attenuates Myocardial Ischemia/Reperfusion Injury by Targeting Nrf2/GPX4 Signalling-Mediated Ferroptosis.
    Mei SL; Xia ZY; Qiu Z; Jia YF; Zhou JJ; Zhou B
    Chin J Integr Med; 2022 Nov; 28(11):983-991. PubMed ID: 35997859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway.
    Yang YY; Deng RR; Xiang DX
    Drug Des Devel Ther; 2024; 18():1499-1514. PubMed ID: 38716368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoliquiritigenin alleviates myocardial ischemia-reperfusion injury by regulating the Nrf2/HO-1/SLC7a11/GPX4 axis in mice.
    Yao D; Bao L; Wang S; Tan M; Xu Y; Wu T; Zhang Z; Gong K
    Free Radic Biol Med; 2024 Aug; 221():1-12. PubMed ID: 38734270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chrysin alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis in rats].
    Shang JF; Jiao JK; Li QN; Lu YH; Wang JY; Yan MX; Wen YL; Huang GJ; Zhang XL; Liu X
    Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(6):1597-1605. PubMed ID: 37005848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 inflammasome deficiency attenuates cerebral ischemia-reperfusion injury by inhibiting ferroptosis.
    Wang Z; Li Y; Ye Y; Zhu H; Zhang J; Wang H; Lei J; Gu L; Zhan L
    Brain Res Bull; 2023 Feb; 193():37-46. PubMed ID: 36435361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [miR-27a induces ferroptosis by inhibiting solute carrier family 7 member-11 (SLC7A11) and causes cerebral ischemia-reperfusion injury in rats].
    Feng Z; Sun H; Zhang J; Zhu L; DU L; Meng A
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Jul; 38(7):617-624. PubMed ID: 35786456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroacupuncture Downregulating Neuronal Ferroptosis in MCAO/R Rats by Activating Nrf2/SLC7A11/GPX4 Axis.
    Zhu W; Dong J; Han Y
    Neurochem Res; 2024 May; ():. PubMed ID: 38819696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loureirin C inhibits ferroptosis after cerebral ischemia reperfusion through regulation of the Nrf2 pathway in mice.
    Liu Y; Mi Y; Wang Y; Meng Q; Xu L; Liu Y; Zhou D; Wang Y; Liang D; Li W; Li N; Hou Y
    Phytomedicine; 2023 May; 113():154729. PubMed ID: 36878093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of CBX7 inhibits ferroptosis in rats with cerebral ischemia and improves cognitive dysfunction by activating the Nrf2/HO-1 pathway.
    Zhang F; Lei F; Xiao X
    J Biosci; 2022; 47():. PubMed ID: 36222130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine post-conditioning alleviates myocardial ischemia-reperfusion injury in rats by ferroptosis inhibition via SLC7A11/GPX4 axis activation.
    Yu P; Zhang J; Ding Y; Chen D; Sun H; Yuan F; Li S; Li X; Yang P; Fu L; Yu S; Zhang J
    Hum Cell; 2022 May; 35(3):836-848. PubMed ID: 35212945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edaravone Ameliorates Cerebral Ischemia-Reperfusion Injury by Downregulating Ferroptosis via the Nrf2/FPN Pathway in Rats.
    Liu W; Wang L; Liu C; Dai Z; Li T; Tang B
    Biol Pharm Bull; 2022; 45(9):1269-1275. PubMed ID: 36047195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of astragaloside IV and Panax notoginseng saponins attenuates cerebral ischaemia-reperfusion injury in rats through ferroptosis and inflammation inhibition via activating Nrf2.
    Kang Z; Xiao Q; Wang L; Xiao L; Tang B
    J Pharm Pharmacol; 2023 Apr; 75(5):666-676. PubMed ID: 36952592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.